Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Seagen Inc (SGEN)

Seagen Inc (SGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Pfizer Raises Forecast on Robust Drug Sales, Offsets COVID-19 Revenue Decline Quiver Quantitative, Inc. - Tue Jul 30, 2024

Pfizer (PFE) raised its annual profit forecast, driven by robust sales in its cancer and heart disease drug segments, particularly benefiting from its recent acquisition of Seagen. The pharmaceutical giant...

JPM : 284.08 (+0.44%)
SGEN : 228.74 (-0.07%)
BNTX : 85.25 (-0.50%)
Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years? Motley Fool - Thu Dec 14, 2023

Pfizer recently outlined expectations for 2024 results in light of an upcoming $43 billion acquisition of Seagen.

MRK : 118.08 (-1.30%)
SGEN : 228.74 (-0.07%)
PFE : 27.59 (+2.03%)
This High-Yield Dividend Stock Is a Proven Wealth Creator Motley Fool - Thu Nov 2, 2023

This heavily sold-off pharma stock is a bargain.

SGEN : 228.74 (-0.07%)
PFE : 27.59 (+2.03%)
Seattle Genetics: Q3 Earnings Snapshot AP - Wed Nov 1, 2023

Seattle Genetics: Q3 Earnings Snapshot

SGEN : 228.74 (-0.07%)
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche? Motley Fool - Sat Oct 21, 2023

The venerable pharmaceutical companies' shares have slumped this year.

SGEN : 228.74 (-0.07%)
REGN : 749.81 (+1.64%)
RHHBY : 48.7800 (+0.97%)
PFE : 27.59 (+2.03%)
BMY : 59.77 (+2.10%)
BNTX : 85.25 (-0.50%)
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research PR Newswire - Fri Oct 20, 2023

/PRNewswire/ -- USA News Group - According to the American Cancer Society in its Cancer Facts & Figures 2023 report, the five-year survival rate for pancreatic...

ONCY : 0.8100 (-3.57%)
ILMN : 121.15 (+2.96%)
MYGN : 4.32 (+0.93%)
SGEN : 228.74 (-0.07%)
ONC.TO : 1.42 (+2.16%)
BNTX : 85.25 (-0.50%)
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research FinancialNewsMedia - Fri Oct 20, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:BNTX),(NASDAQ:SGEN),(NASDAQ:MYGN),(NASDAQ:ILMN) EQNX::TICKER_END

ONCY : 0.8100 (-3.57%)
ILMN : 121.15 (+2.96%)
MYGN : 4.32 (+0.93%)
SGEN : 228.74 (-0.07%)
ONC.TO : 1.42 (+2.16%)
BNTX : 85.25 (-0.50%)
Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment FinancialNewsMedia - Wed Oct 11, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GNLX),(NASDAQ:CRNX),(NYSE:PFE),(NASDAQ:SGEN) EQNX::TICKER_END

ONCY : 0.8100 (-3.57%)
GNLX : 2.37 (-4.44%)
CRNX : 34.29 (+1.84%)
SGEN : 228.74 (-0.07%)
ONC.TO : 1.42 (+2.16%)
PFE : 27.59 (+2.03%)
Navigating the Surge in Pancreatic Cancer: The Innovative Strategies Offering New Hope BayStreet.ca - Tue Oct 10, 2023

USA News Group – Researchers are becoming increasingly concerned with the rates of cancer on the rise among people under 50. A recent study found a nearly 80% global increase in the number of under-50s...

ONCY : 0.8100 (-3.57%)
GNLX : 2.37 (-4.44%)
CRNX : 34.29 (+1.84%)
SGEN : 228.74 (-0.07%)
ONC.TO : 1.42 (+2.16%)
PFE : 27.59 (+2.03%)
2 High-Yield Dividend Stocks to Buy in October Motley Fool - Wed Oct 4, 2023

These two high-yield dividend stocks are too cheap to ignore.

T : 28.99 (-0.38%)
SGEN : 228.74 (-0.07%)
PFE : 27.59 (+2.03%)

Barchart Exclusives

Bill Ackman Is Pounding the Table on Fannie Mae. Should You Buy FNMA Stock Today? Barchart - 4 minutes ago
FNMA stock soars as Bill Ackman dubs it a 10x opportunity. Here’s why Fannie Mae shares are particularly attractive to own in 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.